Leukoaraiosis on MRI in patients with minimally symptomatic obstructive sleep apnoea by Schulz, Ursula G et al.
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2013
Leukoaraiosis on MRI in patients with minimally symptomatic obstructive
sleep apnoea
Schulz, Ursula G; Mason, Rebecca H; Craig, Sonya E; Howard, Sally; Nicoll, Deborah J; Kohler,
Malcolm; Rothwell, Peter M; Stradling, John R
Abstract: BACKGROUND: Obstructive sleep apnoea (OSA) is associated with hypertension, nocturnal
blood pressure (BP) surges, and increased risk of stroke. It may therefore also be associated with a
higher risk of developing leukoaraiosis. Only few data about the prevalence of leukoaraiosis in patients
with OSA, and any association between degrees of severity of either condition, exist. METHODS: We
studied patients who were part of a clinical trial (MOSAIC) in minimally symptomatic OSA. All pa-
tients had brain MRI (T2, FLAIR) at baseline. A single observer assessed the images for the presence
and severity of leukoaraiosis (ARWMC-score). We related the extent of leukoaraiosis to the severity of
OSA (measured by oxygen desaturation index [ODI]) and the presence of other vascular risk factors.
RESULTS: 183 patients (156 men, 85.2%; mean age ± SD = 57.7 ± 7.4 years; median oxygen desatu-
ration index = 9.6, interquartile range = 4.6-16.0) took part in the study. Although 135 (74%) patients
had some leukoaraiosis, this was generally mild. We confirmed the well-known risk factor associations
between leukoaraiosis, increasing age (p < 0.0001) and hypertension (p = 0.003), but we did not find
any association between OSA and leukoaraiosis (p = 0.33), despite both conditions being associated with
increasing current BP and a history of hypertension. CONCLUSION: Our data confirm the well-known
association between leukoaraiosis, age and increasing BP. However, we found no association between OSA
and leukoaraiosis despite some shared risk factor associations. Our findings suggest that OSA is not a
strong independent risk factor for leukoaraiosis. Confounding by hypertension may explain any apparent
association in previously reported studies of patients with severer OSA.
DOI: 10.1159/000348845
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: http://doi.org/10.5167/uzh-90941
Published Version
Originally published at:
Schulz, Ursula G; Mason, Rebecca H; Craig, Sonya E; Howard, Sally; Nicoll, Deborah J; Kohler, Malcolm;
Rothwell, Peter M; Stradling, John R (2013). Leukoaraiosis on MRI in patients with minimally symp-
tomatic obstructive sleep apnoea. Cerebrovascular Diseases, 35(4):363-369. DOI: 10.1159/000348845
E-Mail karger@karger.com
 Original Paper 
 Cerebrovasc Dis 2013;35:363–369
 DOI: 10.1159/000348845 
 Leukoaraiosis on MRI in Patients with 
Minimally Symptomatic Obstructive 
Sleep Apnoea 
 Ursula G. Schulz  a    Rebecca H. Mason  b    Sonya E. Craig  b    Sally Howard  a    
Deborah J. Nicoll  b    Malcolm Kohler  c    Peter M. Rothwell  a    John R. Stradling  b 
 a   Stroke Prevention Research Unit, Nuffield Department of Neurosciences, John Radcliffe Hospital, and 
 b   Oxford Centre for Respiratory Medicine, Oxford Biomedical Research Centre, Churchill Hospital,  Oxford , UK; 
 c   Sleep Disorders Centre and Pulmonary Division, University Hospital of Zürich,  Zürich , Switzerland
 
osis, increasing age (p < 0.0001) and hypertension (p = 
0.003), but we did not find any association between OSA 
and leukoaraiosis (p = 0.33), despite both conditions being 
associated with increasing current BP and a history of hy-
pertension.  Conclusion:  Our data confirm the well-known 
association between leukoaraiosis, age and increasing BP. 
However, we found no association between OSA and leu-
koaraiosis despite some shared risk factor associations. Our 
findings suggest that OSA is not a strong independent risk 
factor for leukoaraiosis. Confounding by hypertension may 
explain any apparent association in previously reported 
studies of patients with severer OSA. 
 Copyright © 2013 S. Karger AG, Basel 
 Introduction 
 Leukoaraiosis or ‘age-related white matter changes 
(ARWMC)’ are commonly observed on CT or MRI 
brain examinations in the elderly  [1] . These lesions are 
thought to be due to chronic ischaemia from damage to 
the small penetrating vessels, endothelial dysfunction, 
and disruption of the blood-brain barrier  [1] . Hyperten-
sion and increasing age are the best established risk fac-
tors  [1–3] . Clinically, leukoaraiosis is associated with 
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 Abstract 
 Background: Obstructive sleep apnoea (OSA) is associated 
with hypertension, nocturnal blood pressure (BP) surges, 
and increased risk of stroke. It may therefore also be associ-
ated with a higher risk of developing leukoaraiosis. Only 
few data about the prevalence of leukoaraiosis in patients 
with OSA, and any association between degrees of severity 
of either condition, exist.  Methods: We studied patients 
who were part of a clinical trial (MOSAIC) in minimally symp-
tomatic OSA. All patients had brain MRI (T2, FLAIR) at base-
line. A single observer assessed the images for the presence 
and severity of leukoaraiosis (ARWMC-score). We related 
the extent of leukoaraiosis to the severity of OSA (measured 
by oxygen desaturation index [ODI]) and the presence of 
other vascular risk factors.  Results: 183 patients (156 men, 
85.2%; mean age ± SD = 57.7 ± 7.4 years; median oxygen 
desaturation index = 9.6, interquartile range = 4.6–16.0) 
took part in the study. Although 135 (74%) patients had 
some leukoaraiosis, this was generally mild. We confirmed 
the well-known risk factor associations between leukoarai-
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cognitive decline, gait disturbance and increased stroke 
risk  [1, 4, 5] . With an ageing population, the prevalence 
of leukoaraiosis and its consequences is set to increase. 
It is therefore important to identify potentially treatable 
risk factors to try and reduce its occurrence.
 Obstructive sleep apnoea (OSA) with daytime symp-
toms affects 2–4% of men and 1–2% of women. Minimal-
ly symptomatic OSA (without excessive daytime sleepi-
ness) is considerably more prevalent  [6, 7] . Severe OSA is 
associated with the development of endothelial dysfunc-
tion, hypertension, atherosclerosis, stroke and myocardial 
infarction  [7–10] . OSA may therefore also be a risk factor 
for leukoaraiosis by promoting endothelial dysfunction 
and the development of hypertension, which could lead to 
white matter changes.
 Only few studies exist of the relationship between OSA 
and leukoaraiosis  [11–14] . These were done in patients 
with already established cerebrovascular disease  [11, 12] , 
or in patients with severe OSA  [13, 14] , and results were 
conflicting. If there was an association between leukoara-
iosis and the more common milder degrees of OSA, OSA 
treatment might reduce the development of leukoaraiosis 
in a considerable number of people, and treatment trials 
might be justified. We studied the prevalence and risk fac-
tor associations of leukoaraiosis in the largest cohort to 
date of patients with minimally symptomatic OSA and 
MRI of the brain.
 Methods 
 This study is a substudy of the MOSAIC trial (Multicentre 
Obstructive Sleep Apnoea Interventional Cardiovascular Trial) 
 [15] , which studied the effect of continuous positive airway pres-
sure (CPAP) therapy in patients with minimally symptomatic 
sleep apnoea on sleepiness and vascular risk factors. Patients were 
randomised to 6 months of CPAP therapy or no intervention. 
Two of the study centres conducted an MRI substudy of OSA and 
leukoaraiosis. This was prespecified in the study protocol, and all 
patients from these two centres underwent MRI brain scanning 
in addition to the general study assessment. As our aim was to 
study the association of OSA and leukoaraiosis independently of 
any treatment, and as MRI scanning was done at baseline, prior 
to any study intervention, we studied all patients as a single, com-
bined cohort, regardless of treatment allocation. These results are 
reported in the current paper. The trial was registered (ISRCTN 
34164388) and approved by all the local ethic committees of the 
participating centres (REC No. 05/Q1604/159).
 Participants 
 Patients were eligible to enter the study if they were aged 45–
75 years, had no history of concerning daytime somnolence, but 
had newly diagnosed, proven OSA on a cardiorespiratory sleep 
study, performed as the routine diagnostic investigation in the 
participating centre. The qualifying severity was defined as an 
oxygen desaturation index (ODI) >7.5, i.e. patients had to have 
at least 7.5 dips of >4% Sa O 2 per hour in their original diagnostic 
sleep study. We used the ODI instead of the apopnea-hypopnea 
index (AHI) for several reasons: first, the ODI, but not the AHI, 
can be obtained from home oximetry. To standardise the study 
ODI (which could thus be different from the entry ODI), all pa-
tients underwent a home oximetry study with a specific oximeter 
(Konica-Minolta, Japan). Second, the ODI is more reproducible 
than the AHI  [16] ; third, hypoxia and re-oxygenation are thought 
to be one of the main provokers of potential damage from OSA 
 [7] , and fourth, in epidemiological studies the ODI is a better 
predictor of vascular associations than the AHI  [17] . The ODI 
therefore seemed to be the best measure to identify any associa-
tion between OSA and leukoaraiosis.
 Clinical Assessment 
 All patients underwent a detailed standardised assessment at 
study entry. This included height, weight, neck, waist and hip 
measurements. Blood pressure (BP) was monitored by home mea-
surements (M7, Omron, Japan). These were made weekly in trip-
licate at the same time of day throughout the 6-month follow-up 
period. All patients had fasting blood tests, including cholesterol, 
glycosylated haemoglobin (HbA1c) and insulin levels.
 MRI Scan 
 All patients with no contra-indications underwent brain MRI 
scanning (GE Sigma Twin Speed 1.5 T) at baseline and after 
6  months. Sequences included axial fast spin echo T2-weighted 
(TR 6,160 ms, TE 105 ms, slice thickness 3 mm, matrix 384 × 256) 
and fast spin echo fluid-attenuated inversion recovery (FLAIR) 
images (TR 8,820 ms, TE 131 ms, slice thickness 3 mm, matrix 
256 × 192). All scans were reviewed by an experienced observer 
(U.G.S.) blinded to OSA severity. In patients who were scanned 
twice, the 2 scans were assessed separately and at least 1 month 
apart. We used the ARWMC score, a well-validated score to assess 
the extent of white matter disease in 10 areas of the brain  [18] , with 
a maximum total score of 30. We used the ARWMC score rather 
than volumetric analysis, as we expected the degree of white matter 
changes in this cohort of relatively young individuals to be mild. 
While volumetric analysis may appear to offer higher precision, 
the relevance of minor differences between scans is uncertain, and 
will include some background noise. The visual semi-quantitative 
assessment with the ARWMC score helped to identify relevant dif-
ferences between scans and offered a more robust analysis.
 Statistical Analysis 
 Values are presented as absolute numbers, percentages, means 
(with standard deviation, SD) or medians (with interquartile 
range) as appropriate, unless otherwise stated. For the BP mea-
surements, we calculated the mean systolic and diastolic BPs from 
the weekly measurements over the study period, as well as the 
VIM (variance independent of the mean) for the systolic BP. This 
is a measure of BP variability which is independent of the mean 
absolute BP measurement  [19] . To assess the association of the 
severity of leukoaraiosis with clinical risk factors, we divided the 
ARWMC scores into quartiles. For each of the clinical variables, 
we performed an ANOVA for trend (continuous variables) or a 
χ 2 test (categorical variables) across quartiles. For variables asso-
ciated at the p < 0.05 significance level in the univariate analysis, 
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we performed a stepwise backward multiple logistic regression 
comparing the top quartile of the ARWMC score versus the oth-
er three categories combined. To assess the association of the ODI 
with any of the clinical risk factors, we divided the cohort into 
quartiles and performed an ANOVA for trend (continuous vari-
ables) or a χ 2 test (categorical variables) across quartiles. All sta-
tistical analyses were performed with SPSS version 18 ® .
 Results 
 There were 238 participants in the two centres con-
ducting the MRI substudy. Of these, 183 (156 men, mean 
age ± SD = 58 ± 7 years) underwent MRI scanning at 
baseline, while 55 patients refused scanning or had a con-
tra-indication. The baseline characteristics of the scanned 
patients are given in  table 1 .
 The analyses in this paper are based on the ARWMC 
score obtained from the FLAIR images, as FLAIR has the 
highest sensitivity for detecting white matter lesions. 
ARWMC scores from the FLAIR scans were slightly 
higher (mean ± SD = 2.4 ± 2.6) than from the T2-weight-
ed scans (1.9 ± 2.5, p < 0.0001, paired t test), but highly 
correlated (Spearman’s ρ = 0.90, p < 0.0001).
 157 patients (86%) had MRI scanning at baseline and 
at 6 months. Readings showed no significant difference 
between scans, and were highly correlated (intraclass cor-
relation coefficient = 0.92, 95% confidence interval = 
0.89–0.94, p < 0.0001) confirming high intrarater reliabil-
ity, and lack of lesion progression over 6 months. Given 
the absence of progression and high agreement between 
first and second scans, we averaged the readings where 
available to increase the robustness of our data. To elimi-
nate any potential effect of CPAP treatment or time, we 
also performed the analysis with only the baseline scans. 
Results were virtually identical.
 The prevalence of leukoaraiosis in this population 
was low, and the extent of disease mild. Forty-eight pa-
tients (26%) had no disease, 90 patients (49%) had very 
mild changes with an ARWMC score of 1–2, and only 
36 patients (20%) had a score of  >4. Imaging examples 
are given in  figure 1 .  Table 1 shows the association of 
disease severity with baseline characteristics. Increasing 
Table 1.  Risk factor association for leukoaraiosis, assessed by ARWMC score
Total (n = 183) Quartile 1 
(n = 48)
Quartile 2 
(n = 51)
Quartile 3 
(n = 48)
Quartile 4 
(n = 36)
phet plin
Male sex 156 (85.2) 41 (85.4) 42 (82.4) 42 (87.5) 31 (86.1) 0.906 0.754
Age, years 57.7±7.4 53.6±6.4 57.1±5.9 58.0±7.8 63.8±5.8 <0.0001 <0.0001
Current smoker 24 (13.1) 5 (10.4) 7 (13.7) 5 (10.4) 7 (19.4) 0.594 0.355
Diabetes mellitus 27 (14.8) 3 (6.3) 7 (13.7) 10 (20.8) 7 (19.4) 0.184 0.045
Hypertension 82 (44.8) 16 (33.3) 22 (43.1) 18 (37.5) 26 (72.2) 0.002 0.003
Height, cm 176.0±7.6 176.3±7.3 175.9±7.9 176.5±7.6 175.3±7.7 0.893 0.699
Weight, kg 97.2±16.4 93.4±15.5 97.0±16.7 100.6±13.8 98.5±20.0 0.230 0.084
BMI 31.5±4.9 30.6±5.3 31.4±5.1 32.1±3.8 32.3±5.7 0.434 0.108
Waist-hip ratio 0.968±0.057 0.954±0.062 0.956±0.055 0.981±0.054 0.988±0.049 0.007 0.001
Neck circumference, cm 42.9±3.5 42.1±3.3 42.7±3.8 43.4±3.4 43.3±3.4 0.251 0.061
ODI 
Median 9.6 12.5 8.7 7.5 12.1 0.104 0.327
Interquartile range 4.6–16.0 5.1–22.5 5.1–14.9 3.2–14.3 7.8–16.6
SBP, mm Hg 130.2±11.7 128.1±10.9 126.2±10.8 132.4±11.9 135.2±12.7 0.002 0.001
DBP, mm Hg 80.8±7.6 81.4±8.6 78.6±7.4 81.2±6.4 82.4±7.3 0.114 0.330
VIM SBP 8.9±2.9 7.8±2.4 9.0±2.8 9.2±2.9 9.8±3.1 0.011 0.001
Total cholesterol, mmol/l 5.17±1.11 5.30±1.19 5.22±0.93 5.33±1.08 4.83±0.87 0.133 0.115
HbA1c, % 5.95±0.80 5.85±0.79 5.94±0.67 6.10±1.01 5.89±0.67 0.460 0.498
Insulin level, pmol/l 94.7±60.5 84.9±49.1 98.1±60.4 91.5±54.5 107.3±79.2 0.377 0.167
 Results are expressed as means ± SD or as absolute number (percentage); phet = p for heterogeneity; plin = p for linear trend; SBP = 
systolic BP; DBP =diastolic BP; VIM = variance independent of the mean; HbA1c = glycosylated haemoglobin. First quartile: ARWMC 
score 0; second quartile: scores 1–2; third quartile: scores 3–4; fourth quartile: score >4. To determine associations with the ARWMC-
score, we used the χ2 test for categorical variables, ANOVA for continuous variables, and the non-parametric Kruskal Wallis test and 
independent samples median test for the ODI. History of hypertension and of diabetes present if recorded in the family physician’s 
medical records or patient on medication.
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severity of leukoaraiosis showed a strong association 
with age, history of hypertension, systolic BP, variability 
(VIM) of systolic BP and waist-to-hip ratio. Cholesterol 
levels were lower in the most severe category of leuko-
araiosis. This may be explained by higher statin use in 
these patients (39 vs. 28% in quartiles 1–3, p = 0.34). In 
the multivariate logistic regression analysis ( table  2 ), 
only age and history of hypertension remained signifi-
cantly associated with leukoaraiosis. Patients with hy-
pertension had a higher BMI (32.8 ± 4.9 vs. 30.5 ± 4.7, 
p = 0.003) and a higher waist-hip ratio (0.98 ± 0.06 vs. 
0.96 ± 0.05, p = 0.007) than non-hypertensive patients.
 Increasing severity of leukoaraiosis was not associated 
with increasingly severe OSA in any analysis. Absolute 
ARWMC scores and ODI showed no significant correla-
tion (Spearman’s ρ = –0.015, p = 0.85). A binary logistic 
regression analysis comparing the quartile of patients 
with the most severe disease versus all other patients 
combined, or versus patients with no leukoaraiosis, did 
not show ODI as a predictor of severe disease (odds ra-
tio = 1.01, 95% confidence interval = 0.98–1.04, p = 0.65, 
and odds ratio = 0.99, 95% confidence interval = 0.96–
1.03, p = 0.75). In a multivariate analysis including AR-
WMC score, age, systolic and diastolic BP and BMI, ODI 
and leukoaraiosis were not associated.
 Table 3 shows risk factor associations across increas-
ing degrees of severity of OSA. As expected, weight, 
BMI, waist-hip ratio and neck circumference were all as-
sociated, as were history of hypertension, systolic and 
diastolic BP, but systolic BP variability and age were not.
 Discussion 
 Our study confirms the widely accepted risk factor as-
sociations for leukoaraiosis with age and hypertension. 
We found no independent association between leukoara-
iosis and OSA, but both were associated with increasing 
BP and waist-hip ratio.
Table 2.  Multivariate logistic regression of variables associated 
with ARWMC score, using a backward stepwise procedure
Characteristic OR 95% CI p
Age (per year) 1.16 1.08–1.24 <0.0001
History of hypertension 2.82 1.19–6.69 0.019
 OR = Odds ratio; CI = confidence interval. Variables included 
were those showing a statistically significant association (plin < 
0.05) in the univariate analyses: age, mean systolic BP, variance 
independent of the mean of the systolic BP, waist-hip ratio, his-
tory of hypertension.
 Fig. 1. Examples of FLAIR scans of study 
participants with different degrees of leu-
koaraiosis. The ARWMC score is shown 
next to the images, and reflects examples 
for each of the quartiles used in the analysis 
(table 1). 
D
ow
nl
oa
de
d 
by
: 
Un
ive
rs
itä
t Z
ür
ich
,  
Ze
nt
ra
lb
ib
lio
th
ek
 Z
ür
ich
   
   
   
 
13
0.
60
.4
7.
22
 - 
6/
9/
20
16
 2
:5
6:
02
 P
M
 Leukoaraiosis in OSA  Cerebrovasc Dis 2013;35:363–369
DOI: 10.1159/000348845
367
 In this cohort, 26% of the participants had no leuko-
araiosis, and the degree of leukoaraiosis in the remainder 
was generally mild. This may partly have been due to the 
relatively young mean age of 58 years. While we had no 
control group, other studies offer some comparison to 
the prevalence of leukoaraiosis in populations without 
OSA. In the Rotterdam Scan Study only 5% of patients 
aged 60–90 years were completely free of disease  [20] . 
This percentage was highest in the 60- to 70-year-olds, of 
whom 13% had no subcortical lesions and 32% had no 
periventricular lesions, although the authors do not 
comment on how many had no lesions at all. In the Car-
diovascular Health Study  [21] , approximately 30% of 
participants with a mean age of 75 years had no, or only 
mild, leukoaraiosis. While no direct comparison is pos-
sible, the prevalence of leukoaraiosis in our cohort ap-
pears similar to these general populations of a similar age 
range, suggesting that OSA is not a strong risk factor for 
this condition.
 Our study confirms the strong association of increas-
ing age and a history of hypertension with leukoaraiosis. 
As others, we also found an association of leukoaraiosis 
with current systolic BP and its variability, and with dia-
stolic BP, which was highest in the patients with the most 
severe disease  [1, 22–24] . In the multivariate analysis cur-
rent systolic BP was no longer associated with leukoara-
iosis. This indicates that a history of hypertension is more 
strongly associated with leukoaraiosis than current BP 
(influenced of course by current treatment), and that 
long-standing BP changes are required for leukoaraiosis 
to develop. This is further supported by the lack of disease 
progression over the 6-month study period.
 OSA and leukoaraiosis were both associated with in-
creasing waist-hip ratio in the univariate analysis. Obe-
sity is an important risk factor for OSA  [7] , and the as-
sociation with waist-hip ratio was expected. However, 
the association of waist-hip ratio with leukoaraiosis was 
surprising. It was absent in the multivariate analysis, and 
may simply reflect a higher rate of obesity in hyperten-
sive subjects. Alternatively, obesity may promote the re-
lease of inflammatory mediators, which induce vascular 
damage and may lead to leukoaraiosis  [25] .
 OSA and leukoaraiosis were not associated with each 
other, although both were associated with hypertension. 
A possible explanation is the different temporal relation-
ship of either condition with hypertension: whereas OSA 
Table 3.  Risk factor associations of OSA measured by the ODI
Total (n = 183) Quartile 1 
(n = 48)
Quartile 2 
(n = 44)
Quartile 3 
(n = 46)
Quartile 4 
(n = 45)
phet plin
Male sex 156 (85.2) 40 (83.3) 37 (84.1) 39 (84.8) 40 (88.9) 0.880 0.462
Age, years 57.7±7.4 55.8±6.8 57.5±7.6 59.7±7.1 57.9±7.6 0.083 0.071
Current smoker 24 (13.1) 7 (14.6) 4 (9.1) 7 (15.2) 6 (13.3) 0.826 0.929
Diabetes mellitus 27 (14.8) 6 (12.5) 7 (15.9) 7 (15.2) 7 (15.6) 0.965 0.710
Hypertension 81 (44.3) 19 (39.6) 14 (31.8) 22 (47.8) 26 (57.8) 0.080 0.034
Height, cm 176.0±7.6 178.2±8.1 175.0±7.1 175.2±8.2 175.5±6.5 0.140 0.106
Weight, kg 97.2±16.4 95.5±13.9 92.2±15.7 100.1±16.4 100.9±18.3 0.063 0.039
BMI 31.5±4.9 30.2±4.0 30.3±4.8 32.8±5.1 32.6±5.2 0.021 0.006
Waist-hip ratio 0.968±0.057 0.956±0.057 0.959±0.056 0.982±0.055 0.977±0.055 0.073 0.023
Neck circumference, cm 42.85±3.50 41.9±3.3 42.9±3.9 43.2±3.4 43.4±3.3 0.187 0.042
ARWMC score 2.3±1.1 2.7±2.3 2.5±2.3 3.1±2.7 2.9±3.5 0.779 0.500
SBP, mm Hg 130.4±11.7 128.2±10.6 127.2±12.7 134.0±13.0 131.2±10.7 0.031 0.048
DBP, mm Hg 82.1±7.6 80.4±8.3 80.7±7.9 85.0±6.5 82.5±7.0 0.014 0.034
VIM SBP 8.9±2.9 8.1±2.6 9.4±2.9 9.2±3.0 9.0±2.9 0.169 0.184
Total cholesterol, mmol/l 5.17±1.11 5.01±1.08 5.37±1.21 5.37±0.98 4.94±1.11 0.113 0.829
HbA1c, % 5.95±0.80 5.98±0.83 5.82±0.53 5.99±0.92 6.01±0.89 0.668 0.662
Insulin level, pmol/l 94.7±60.5 88.4±48.7 87.4±55.9 89.0±53.4 114.4±78.1 0.095 0.049
 Results are expressed as means ± SD or as absolute number (percentage); phet = p for heterogeneity; plin = p for linear trend; SBP = 
systolic BP; DBP = diastolic BP; VIM = variance independent of the mean; HbA1c = glycosylated haemoglobin. Participants were di-
vided into quartiles according to the ODI. The median ODI (and interquartile range) in the different quartiles was: first quartile, 3.0 
(1.9–3.7); second quartile, 7.4 (6.0–8.0); third quartile, 12.9 (11.4–14.7); fourth quartile, 27.0 (21.2–41.1).
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as an aetiological factor would precede the development 
of hypertension, leukoaraiosis would follow, and any ef-
fect of OSA on leukoaraiosis via hypertension would have 
a delay, often of many years. This is difficult to identify in 
a cross-sectional study. Our findings suggest that to iden-
tify any association between OSA and leukoaraiosis, long-
term follow-up studies would be required. Furthermore, 
if any association between OSA and leukoaraiosis was 
due to confounding by hypertension, treatment trials of 
OSA could consider BP rather than leukoaraiosis as an 
outcome measure. Indeed, several studies have already 
shown that treatment of OSA with CPAP leads to a mod-
est but significant reduction in BP  [10, 26] . However, it is 
still unknown if this is reflected in any reduced risk of 
stroke or leukoaraiosis.
 Previous studies of leukoaraiosis and OSA have 
shown conflicting results. One study of 78 stroke pa-
tients showed that sleep-disordered breathing was more 
common after stroke in patients with leukoaraiosis than 
those without  [11] . Another study showed that sleep-
disordered breathing was more common in multi-in-
farct dementia than other types of dementia  [12] . As 
both studies included only patients with already estab-
lished cerebrovascular disease, it is unclear if this caused 
the disordered breathing, or if the breathing disorder 
was pre-existing, possibly promoting cerebrovascular 
injury. The Cardiovascular Health Study found that pa-
tients with progressive leukoaraiosis had a higher prev-
alence of central, but not of obstructive sleep apnoea 
 [27] . This study emphasises the importance of distin-
guishing different types of breathing disorder, and con-
firms our finding that OSA is not associated with leuko-
araiosis. Two other small studies of patients with mod-
erate to severe OSA had conflicting findings: whereas 
one study found a higher prevalence of silent brain in-
farction in patients than  in healthy controls  [14] , the 
other did not  [13] .
 A potential limiting factor of our study is that we used 
standard imaging sequences, and assessed visible white 
matter changes, as we felt this would provide the clini-
cally most robust data. However, the extent of disease in 
our cohort was mild. Changes in normal-appearing white 
matter in OSA patients have been reported with other 
MRI methods, e.g. magnetic resonance spectroscopy  [28] 
or diffusion tensor imaging  [29] . More complex newer 
imaging sequences, specifically in more mildly affected 
patients, may form an important approach in future re-
search of the effects of OSA on the brain.
 Conclusion 
 We found no association between OSA and leukoara-
iosis in this large patient cohort. However, we identified 
hypertension as a possible mechanism by which OSA 
could promote the development of leukoaraiosis. Con-
founding by hypertension may explain any apparent as-
sociation in previously reported studies of patients with 
more severe OSA.
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